Tumour microvessel density as predictor of chemotherapy response in breastcancer patients
2002 (English)In: British Journal of Cancer, ISSN 0007-0920, E-ISSN 1532-1827, Vol. 86, 1905-1908 p.Article in journal (Refereed) Published
The aim of this study was to evaluate the predictive value of intratumoural microvessel density in breast cancer. We studied immunohistochemically primary tumours of 104 patients with metastasised breast cancer who took part in a randomised multicentre trial comparing docetaxel to sequential methotrexate and 5-fluorouracil. Vessels were highlighted with factor VIII staining and counted microscopically. Microvessel density was compared with clinical response to chemotherapy and patient survival. The microvessel density of the primary tumour was not significantly associated with patient's response to chemotherapy, time to progression or overall survival in the whole patient population or in the docetaxel or methotrexate and 5-fluorouracil groups. However, disease-free survival was longer in patients with low microvessel density (P=0.01). These findings suggest that microvessel density of the primary tumour cannot be used as a predictive marker for chemotherapy response in advanced breast cancer.
Place, publisher, year, edition, pages
2002. Vol. 86, 1905-1908 p.
Medical and Health Sciences
IdentifiersURN: urn:nbn:se:uu:diva-64241DOI: 10.1038/sj.bjc.6600325PubMedID: 12085184OAI: oai:DiVA.org:uu-64241DiVA: diva2:92152